...
首页> 外文期刊>Recent Patents on Endocrine, Metabolic & Immune Drug Discovery >Hepatic Nuclear Factor-4, a Key Transcription Factor at the Crossroads Between Architecture and Function of Epithelia
【24h】

Hepatic Nuclear Factor-4, a Key Transcription Factor at the Crossroads Between Architecture and Function of Epithelia

机译:肝核因子4,在上皮细胞的结构和功能之间的十字路口的关键转录因子

获取原文
获取原文并翻译 | 示例

摘要

Hepatic nuclear factor-4 (HNF-4) is a transcription factor and a member of the large family of nuclear receptors. It was first cloned from liver but is expressed also in kidney, pancreas and intestine. Three genes encoding three isoforms have been identified, HNF- 4α and γ, in mammals, drosophila and xenopus and HNF-4β, exclusively in xenopus. HNF-4α is the best studied isoform, especially in liver. Such studies put HNF-4α at the crossroads between architecture and function of epithelia, as it induces expression of cell/cell junction proteins while it also controls glucido-lipidic metabolism and drug metabolizing enzyme genes. Furthermore, mutations in the HNF-4α gene lead to a metabolic disease in humans, Maturity Onset Diabetes of the Young-1 (MODY-1). The existence of a “true ligand” is not clearly established but a “structural” fatty acid is present in the ligand binding pocket of HNF-4α and γ. Consequently, activity of HNF-4 can be modulated by the interaction with co-regulators or by post-translational modifications. Then, HNF-4 is a potential direct or indirect target for pharmacologic drugs, with a special interest for the intestinal epithelium which is the primary site of metabolic control, due to its roles in nutrient absorption and in sensing energy. The patents related to the HNF-4α gene are also discussed in this article.
机译:肝核因子4(HNF-4)是转录因子,是核受体大家族的成员。它首先从肝脏克隆,但在肾脏,胰腺和肠中也表达。在哺乳动物,果蝇和非洲爪蟾中已经鉴定出编码三种同工型的三个基因HNF-4α和γ,而在非洲爪蟾中仅鉴定了HNF-4β。 HNF-4α是研究得最好的亚型,尤其是在肝脏中。此类研究将HNF-4α置于上皮细胞的结构和功能之间的十字路口,因为它诱导细胞/细胞连接蛋白的表达,同时它还控制糖脂-脂质代谢和药物代谢酶基因。此外,HNF-4α基因的突变会导致人类的新陈代谢疾病,即Young-1的成熟期糖尿病(MODY-1)。 HNF-4α和γ的配体结合口袋中没有明确确定“真正的配体”的存在,但存在“结构性”脂肪酸。因此,HNF-4的活性可以通过与辅助调节剂的相互作用或翻译后修饰来调节。然后,HNF-4是潜在的直接或间接药理药物靶标,由于其在营养吸收和传感能量中的作用,对作为代谢控制的主要部位的肠上皮特别感兴趣。本文还讨论了与HNF-4α基因有关的专利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号